Skip to main content
KURA filings

Corporate insider profile

Troy Edward Wilson Filing Activity

Latest reported as President and CEO of Kura Oncology, Inc. (KURA).

Purchase filings
1
Reported companies
2
Net open-market value
$1,034,252
Latest transaction
Aug 17, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 17, 2026Kura Oncology, Inc. (KURA)President and CEOOpen Market Purchase100,000$11.12$1,112,000
Jun 12, 2026PUMA BIOTECHNOLOGY, INC. (PBYI)Corporate insiderSale10,800$7.20$77,748